 | • レポートコード：MRC2-11QY14156 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はポンチングリオーマ治療薬のグローバル市場について調査・分析したレポートです。種類別（8H-9、A-10、AdRTSIL-12、ジマレイン酸アファチニブ、AZD-1775、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ポンチングリオーマ治療薬の競争状況、市場シェア ・世界のポンチングリオーマ治療薬市場：種類別市場規模 2015年-2020年（8H-9、A-10、AdRTSIL-12、ジマレイン酸アファチニブ、AZD-1775、その他） ・世界のポンチングリオーマ治療薬市場：種類別市場規模予測 2021年-2026年（8H-9、A-10、AdRTSIL-12、ジマレイン酸アファチニブ、AZD-1775、その他） ・世界のポンチングリオーマ治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界のポンチングリオーマ治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米のポンチングリオーマ治療薬市場分析：米国、カナダ ・ヨーロッパのポンチングリオーマ治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのポンチングリオーマ治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のポンチングリオーマ治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのポンチングリオーマ治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Arog Pharmaceuticals, Inc.、Burzynski Research Institute, Inc.、Loxo Oncology, Inc.、Medicenna Therapeutics, Inc.、Medivation, Inc.、Novogen Limited、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Pontine Glioma Drug Market
The global Pontine Glioma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pontine Glioma Drug Scope and Market Size
Pontine Glioma Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pontine Glioma Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pontine Glioma Drug market is segmented into
8H-9
A-10
AdRTSIL-12
Afatinib Dimaleate
AZD-1775
Others
Segment by Application, the Pontine Glioma Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Pontine Glioma Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pontine Glioma Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pontine Glioma Drug Market Share Analysis
Pontine Glioma Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pontine Glioma Drug business, the date to enter into the Pontine Glioma Drug market, Pontine Glioma Drug product introduction, recent developments, etc.
The major vendors covered:
Arog Pharmaceuticals, Inc.
Burzynski Research Institute, Inc.
Loxo Oncology, Inc.
Medicenna Therapeutics, Inc.
Medivation, Inc.
Novogen Limited
Sanofi
…
1 Study Coverage
1.1 Pontine Glioma Drug Product Introduction
1.2 Market Segments
1.3 Key Pontine Glioma Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pontine Glioma Drug Market Size Growth Rate by Type
1.4.2 8H-9
1.4.3 A-10
1.4.4 AdRTSIL-12
1.4.5 Afatinib Dimaleate
1.4.6 AZD-1775
1.4.7 Others
1.5 Market by Application
1.5.1 Global Pontine Glioma Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pontine Glioma Drug Market Size, Estimates and Forecasts
2.1.1 Global Pontine Glioma Drug Revenue 2015-2026
2.1.2 Global Pontine Glioma Drug Sales 2015-2026
2.2 Global Pontine Glioma Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pontine Glioma Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pontine Glioma Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pontine Glioma Drug Competitor Landscape by Players
3.1 Pontine Glioma Drug Sales by Manufacturers
3.1.1 Pontine Glioma Drug Sales by Manufacturers (2015-2020)
3.1.2 Pontine Glioma Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Pontine Glioma Drug Revenue by Manufacturers
3.2.1 Pontine Glioma Drug Revenue by Manufacturers (2015-2020)
3.2.2 Pontine Glioma Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pontine Glioma Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pontine Glioma Drug Revenue in 2019
3.2.5 Global Pontine Glioma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pontine Glioma Drug Price by Manufacturers
3.4 Pontine Glioma Drug Manufacturing Base Distribution, Product Types
3.4.1 Pontine Glioma Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pontine Glioma Drug Product Type
3.4.3 Date of International Manufacturers Enter into Pontine Glioma Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pontine Glioma Drug Market Size by Type (2015-2020)
4.1.1 Global Pontine Glioma Drug Sales by Type (2015-2020)
4.1.2 Global Pontine Glioma Drug Revenue by Type (2015-2020)
4.1.3 Pontine Glioma Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pontine Glioma Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Pontine Glioma Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Pontine Glioma Drug Revenue Forecast by Type (2021-2026)
4.2.3 Pontine Glioma Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pontine Glioma Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pontine Glioma Drug Market Size by Application (2015-2020)
5.1.1 Global Pontine Glioma Drug Sales by Application (2015-2020)
5.1.2 Global Pontine Glioma Drug Revenue by Application (2015-2020)
5.1.3 Pontine Glioma Drug Price by Application (2015-2020)
5.2 Pontine Glioma Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Pontine Glioma Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Pontine Glioma Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Pontine Glioma Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pontine Glioma Drug by Country
6.1.1 North America Pontine Glioma Drug Sales by Country
6.1.2 North America Pontine Glioma Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pontine Glioma Drug Market Facts & Figures by Type
6.3 North America Pontine Glioma Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Pontine Glioma Drug by Country
7.1.1 Europe Pontine Glioma Drug Sales by Country
7.1.2 Europe Pontine Glioma Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pontine Glioma Drug Market Facts & Figures by Type
7.3 Europe Pontine Glioma Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pontine Glioma Drug by Region
8.1.1 Asia Pacific Pontine Glioma Drug Sales by Region
8.1.2 Asia Pacific Pontine Glioma Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pontine Glioma Drug Market Facts & Figures by Type
8.3 Asia Pacific Pontine Glioma Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pontine Glioma Drug by Country
9.1.1 Latin America Pontine Glioma Drug Sales by Country
9.1.2 Latin America Pontine Glioma Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pontine Glioma Drug Market Facts & Figures by Type
9.3 Central & South America Pontine Glioma Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pontine Glioma Drug by Country
10.1.1 Middle East and Africa Pontine Glioma Drug Sales by Country
10.1.2 Middle East and Africa Pontine Glioma Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pontine Glioma Drug Market Facts & Figures by Type
10.3 Middle East and Africa Pontine Glioma Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Arog Pharmaceuticals, Inc.
11.1.1 Arog Pharmaceuticals, Inc. Corporation Information
11.1.2 Arog Pharmaceuticals, Inc. Description and Business Overview
11.1.3 Arog Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Arog Pharmaceuticals, Inc. Pontine Glioma Drug Products Offered
11.1.5 Arog Pharmaceuticals, Inc. Related Developments
11.2 Burzynski Research Institute, Inc.
11.2.1 Burzynski Research Institute, Inc. Corporation Information
11.2.2 Burzynski Research Institute, Inc. Description and Business Overview
11.2.3 Burzynski Research Institute, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Burzynski Research Institute, Inc. Pontine Glioma Drug Products Offered
11.2.5 Burzynski Research Institute, Inc. Related Developments
11.3 Loxo Oncology, Inc.
11.3.1 Loxo Oncology, Inc. Corporation Information
11.3.2 Loxo Oncology, Inc. Description and Business Overview
11.3.3 Loxo Oncology, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Loxo Oncology, Inc. Pontine Glioma Drug Products Offered
11.3.5 Loxo Oncology, Inc. Related Developments
11.4 Medicenna Therapeutics, Inc.
11.4.1 Medicenna Therapeutics, Inc. Corporation Information
11.4.2 Medicenna Therapeutics, Inc. Description and Business Overview
11.4.3 Medicenna Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Medicenna Therapeutics, Inc. Pontine Glioma Drug Products Offered
11.4.5 Medicenna Therapeutics, Inc. Related Developments
11.5 Medivation, Inc.
11.5.1 Medivation, Inc. Corporation Information
11.5.2 Medivation, Inc. Description and Business Overview
11.5.3 Medivation, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Medivation, Inc. Pontine Glioma Drug Products Offered
11.5.5 Medivation, Inc. Related Developments
11.6 Novogen Limited
11.6.1 Novogen Limited Corporation Information
11.6.2 Novogen Limited Description and Business Overview
11.6.3 Novogen Limited Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novogen Limited Pontine Glioma Drug Products Offered
11.6.5 Novogen Limited Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Pontine Glioma Drug Products Offered
11.7.5 Sanofi Related Developments
11.1 Arog Pharmaceuticals, Inc.
11.1.1 Arog Pharmaceuticals, Inc. Corporation Information
11.1.2 Arog Pharmaceuticals, Inc. Description and Business Overview
11.1.3 Arog Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Arog Pharmaceuticals, Inc. Pontine Glioma Drug Products Offered
11.1.5 Arog Pharmaceuticals, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pontine Glioma Drug Market Estimates and Projections by Region
12.1.1 Global Pontine Glioma Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Pontine Glioma Drug Revenue Forecast by Regions 2021-2026
12.2 North America Pontine Glioma Drug Market Size Forecast (2021-2026)
12.2.1 North America: Pontine Glioma Drug Sales Forecast (2021-2026)
12.2.2 North America: Pontine Glioma Drug Revenue Forecast (2021-2026)
12.2.3 North America: Pontine Glioma Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Pontine Glioma Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Pontine Glioma Drug Sales Forecast (2021-2026)
12.3.2 Europe: Pontine Glioma Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Pontine Glioma Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pontine Glioma Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pontine Glioma Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pontine Glioma Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pontine Glioma Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Pontine Glioma Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Pontine Glioma Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Pontine Glioma Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Pontine Glioma Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pontine Glioma Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pontine Glioma Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pontine Glioma Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pontine Glioma Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pontine Glioma Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pontine Glioma Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Pontine Glioma Drug Market Segments
Table 2. Ranking of Global Top Pontine Glioma Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pontine Glioma Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 8H-9
Table 5. Major Manufacturers of A-10
Table 6. Major Manufacturers of AdRTSIL-12
Table 7. Major Manufacturers of Afatinib Dimaleate
Table 8. Major Manufacturers of AZD-1775
Table 9. Major Manufacturers of Others
Table 10. Global Pontine Glioma Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Pontine Glioma Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Pontine Glioma Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Pontine Glioma Drug Sales Market Share by Regions (2015-2020)
Table 14. Global Pontine Glioma Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Pontine Glioma Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Pontine Glioma Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Pontine Glioma Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Pontine Glioma Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pontine Glioma Drug as of 2019)
Table 19. Pontine Glioma Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Pontine Glioma Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Pontine Glioma Drug Price (2015-2020) (USD/Pcs)
Table 22. Pontine Glioma Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pontine Glioma Drug Product Type
Table 24. Date of International Manufacturers Enter into Pontine Glioma Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Pontine Glioma Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global Pontine Glioma Drug Sales Share by Type (2015-2020)
Table 28. Global Pontine Glioma Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Pontine Glioma Drug Revenue Share by Type (2015-2020)
Table 30. Pontine Glioma Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Pontine Glioma Drug Sales by Application (2015-2020) (K Pcs)
Table 32. Global Pontine Glioma Drug Sales Share by Application (2015-2020)
Table 33. North America Pontine Glioma Drug Sales by Country (2015-2020) (K Pcs)
Table 34. North America Pontine Glioma Drug Sales Market Share by Country (2015-2020)
Table 35. North America Pontine Glioma Drug Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Pontine Glioma Drug Revenue Market Share by Country (2015-2020)
Table 37. North America Pontine Glioma Drug Sales by Type (2015-2020) (K Pcs)
Table 38. North America Pontine Glioma Drug Sales Market Share by Type (2015-2020)
Table 39. North America Pontine Glioma Drug Sales by Application (2015-2020) (K Pcs)
Table 40. North America Pontine Glioma Drug Sales Market Share by Application (2015-2020)
Table 41. Europe Pontine Glioma Drug Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Pontine Glioma Drug Sales Market Share by Country (2015-2020)
Table 43. Europe Pontine Glioma Drug Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Pontine Glioma Drug Revenue Market Share by Country (2015-2020)
Table 45. Europe Pontine Glioma Drug Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Pontine Glioma Drug Sales Market Share by Type (2015-2020)
Table 47. Europe Pontine Glioma Drug Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Pontine Glioma Drug Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Pontine Glioma Drug Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Pontine Glioma Drug Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Pontine Glioma Drug Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Pontine Glioma Drug Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Pontine Glioma Drug Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Pontine Glioma Drug Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Pontine Glioma Drug Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Pontine Glioma Drug Sales Market Share by Application (2015-2020)
Table 57. Latin America Pontine Glioma Drug Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Pontine Glioma Drug Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Pontine Glioma Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Pontine Glioma Drug Revenue Market Share by Country (2015-2020)
Table 61. Latin America Pontine Glioma Drug Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Pontine Glioma Drug Sales Market Share by Type (2015-2020)
Table 63. Latin America Pontine Glioma Drug Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Pontine Glioma Drug Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Pontine Glioma Drug Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Pontine Glioma Drug Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Pontine Glioma Drug Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Pontine Glioma Drug Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Pontine Glioma Drug Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Pontine Glioma Drug Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Pontine Glioma Drug Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Pontine Glioma Drug Sales Market Share by Application (2015-2020)
Table 73. Arog Pharmaceuticals, Inc. Corporation Information
Table 74. Arog Pharmaceuticals, Inc. Description and Major Businesses
Table 75. Arog Pharmaceuticals, Inc. Pontine Glioma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Arog Pharmaceuticals, Inc. Product
Table 77. Arog Pharmaceuticals, Inc. Recent Development
Table 78. Burzynski Research Institute, Inc. Corporation Information
Table 79. Burzynski Research Institute, Inc. Description and Major Businesses
Table 80. Burzynski Research Institute, Inc. Pontine Glioma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Burzynski Research Institute, Inc. Product
Table 82. Burzynski Research Institute, Inc. Recent Development
Table 83. Loxo Oncology, Inc. Corporation Information
Table 84. Loxo Oncology, Inc. Description and Major Businesses
Table 85. Loxo Oncology, Inc. Pontine Glioma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Loxo Oncology, Inc. Product
Table 87. Loxo Oncology, Inc. Recent Development
Table 88. Medicenna Therapeutics, Inc. Corporation Information
Table 89. Medicenna Therapeutics, Inc. Description and Major Businesses
Table 90. Medicenna Therapeutics, Inc. Pontine Glioma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Medicenna Therapeutics, Inc. Product
Table 92. Medicenna Therapeutics, Inc. Recent Development
Table 93. Medivation, Inc. Corporation Information
Table 94. Medivation, Inc. Description and Major Businesses
Table 95. Medivation, Inc. Pontine Glioma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Medivation, Inc. Product
Table 97. Medivation, Inc. Recent Development
Table 98. Novogen Limited Corporation Information
Table 99. Novogen Limited Description and Major Businesses
Table 100. Novogen Limited Pontine Glioma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Novogen Limited Product
Table 102. Novogen Limited Recent Development
Table 103. Sanofi Corporation Information
Table 104. Sanofi Description and Major Businesses
Table 105. Sanofi Pontine Glioma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Sanofi Product
Table 107. Sanofi Recent Development
Table 108. Global Pontine Glioma Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 109. Global Pontine Glioma Drug Sales Market Share Forecast by Regions (2021-2026)
Table 110. Global Pontine Glioma Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 111. Global Pontine Glioma Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 112. North America: Pontine Glioma Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. North America: Pontine Glioma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Europe: Pontine Glioma Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Europe: Pontine Glioma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Asia Pacific: Pontine Glioma Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 117. Asia Pacific: Pontine Glioma Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 118. Latin America: Pontine Glioma Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Latin America: Pontine Glioma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Middle East and Africa: Pontine Glioma Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 121. Middle East and Africa: Pontine Glioma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 123. Key Challenges
Table 124. Market Risks
Table 125. Main Points Interviewed from Key Pontine Glioma Drug Players
Table 126. Pontine Glioma Drug Customers List
Table 127. Pontine Glioma Drug Distributors List
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Pontine Glioma Drug Product Picture
Figure 2. Global Pontine Glioma Drug Sales Market Share by Type in 2020 & 2026
Figure 3. 8H-9 Product Picture
Figure 4. A-10 Product Picture
Figure 5. AdRTSIL-12 Product Picture
Figure 6. Afatinib Dimaleate Product Picture
Figure 7. AZD-1775 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pontine Glioma Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Clinic
Figure 11. Hospital
Figure 12. Others
Figure 13. Pontine Glioma Drug Report Years Considered
Figure 14. Global Pontine Glioma Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Pontine Glioma Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Pontine Glioma Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Pontine Glioma Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Pontine Glioma Drug Sales Market Share by Region in 2019
Figure 19. Global Pontine Glioma Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Pontine Glioma Drug Revenue Market Share by Region in 2019
Figure 21. Global Pontine Glioma Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Pontine Glioma Drug Revenue in 2019
Figure 23. Pontine Glioma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Pontine Glioma Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Pontine Glioma Drug Sales Market Share by Type in 2019
Figure 26. Global Pontine Glioma Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Pontine Glioma Drug Revenue Market Share by Type in 2019
Figure 28. Global Pontine Glioma Drug Market Share by Price Range (2015-2020)
Figure 29. Global Pontine Glioma Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Pontine Glioma Drug Sales Market Share by Application in 2019
Figure 31. Global Pontine Glioma Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Pontine Glioma Drug Revenue Market Share by Application in 2019
Figure 33. North America Pontine Glioma Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Pontine Glioma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Pontine Glioma Drug Sales Market Share by Country in 2019
Figure 36. North America Pontine Glioma Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Pontine Glioma Drug Market Share by Type in 2019
Figure 42. North America Pontine Glioma Drug Market Share by Application in 2019
Figure 43. Europe Pontine Glioma Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Pontine Glioma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Pontine Glioma Drug Sales Market Share by Country in 2019
Figure 46. Europe Pontine Glioma Drug Revenue Market Share by Country in 2019
Figure 47. Germany Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Pontine Glioma Drug Market Share by Type in 2019
Figure 58. Europe Pontine Glioma Drug Market Share by Application in 2019
Figure 59. Asia Pacific Pontine Glioma Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Pontine Glioma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Pontine Glioma Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Pontine Glioma Drug Revenue Market Share by Region in 2019
Figure 63. China Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Pontine Glioma Drug Market Share by Type in 2019
Figure 86. Asia Pacific Pontine Glioma Drug Market Share by Application in 2019
Figure 87. Latin America Pontine Glioma Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Pontine Glioma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Pontine Glioma Drug Sales Market Share by Country in 2019
Figure 90. Latin America Pontine Glioma Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Pontine Glioma Drug Market Share by Type in 2019
Figure 98. Latin America Pontine Glioma Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Pontine Glioma Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Pontine Glioma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Pontine Glioma Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Pontine Glioma Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Pontine Glioma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Pontine Glioma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Pontine Glioma Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Pontine Glioma Drug Market Share by Application in 2019
Figure 111. North America Pontine Glioma Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Pontine Glioma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Pontine Glioma Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Pontine Glioma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Pontine Glioma Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Pontine Glioma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Pontine Glioma Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Pontine Glioma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Pontine Glioma Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Pontine Glioma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
成人用悪性神経膠腫治療薬の世界市場（～2026年） Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at approximately 12 months. Malignant gliomas are included in the category of rare diseases, and the orphan drug status is granted for the drug candidates in the pip…- 悪性神経膠腫の世界市場（～2026年） Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers. In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and p…
- 視神経膠腫の世界市場（～2026年） An optic nerve glioma is a type of brain tumor. There are multiple kinds of brain tumors. Typically, each type of tumor is named after the kinds of cells it affects. Most optic nerve gliomas are considered low-grade and don’t grow as quickly as other types of brain tumors. They are found in the opti…
- 悪性神経膠腫治療の世界市場（～2026年） Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers. In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and p…
- 悪性神経膠腫治療薬の世界市場（～2026年） Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers. In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and p…